SEC Form 4 · accession 0000899243-16-015279
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Mylod Jr.
Director
Period of report
Mar 3, 2016
Accepted (ET)
Mar 4, 2016 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 3, 2016 | P | 20,000 | $15.78 | A | 20,000 | I | See Footnote |
| Ordinary Shares | holding | — | — | — | 148,114 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by Annox Capital LLC, over which Mr. Mylod possesses sole voting and investment power.